MicroRNA-23a is involved in tumor necrosis factor-α induced apoptosis in mesenchymal stem cells and myocardial infarction

Experimental and Molecular Pathology

Volumn 97, Issue 1, 2014, Pages 23-30

  Mao, Jianqiang ^a,b   Lv, Zhiqian ^a   Zhuang, Yu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Apoptosis; Caspase; Mesenchymal stem cells; MicroRNA; Myocardial infarction

Indexed keywords

CASPASE 7; MICRORNA 23A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOLECULAR PATHOLOGY; NONHUMAN; RAT;

APOPTOSIS; CASPASE; MESENCHYMAL STEM CELLS; MICRORNA; MYOCARDIAL INFARCTION;

3' UNTRANSLATED REGIONS; ANIMALS; APOPTOSIS; CASPASE 7; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HEART VENTRICLES; HEK293 CELLS; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICRORNAS; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84901008516     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2013.11.005     Document Type: Article

References (54)

1. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
2. Bialik S., Geenen D.L., Sasson I.E., et al. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J. Clin. Invest. 1997, 100:1363-1372.
3. Bolli R., Chugh A.R., D'Amario D., et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011, 378:1847-1857.
4. Brocheriou V., Hagege A.A., Oubenaissa A., et al. Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J. Gene Med. 2000, 2:326-333.
5. Dai W., Hale S.L., Martin B.J., et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 2005, 112:214-223.
6. de Macedo Braga L.M., Lacchini S., Schaan B.D., et al. In situ delivery of bone marrow cells and mesenchymal stem cells improves cardiovascular function in hypertensive rats submitted to myocardial infarction. J. Biomed. Sci. 2008, 15:365-374.
7. Fazel S., Chen L., Weisel R.D., et al. Cell transplantation preserves cardiac function after infarction by infarct stabilization: augmentation by stem cell factor. J. Thorac. Cardiovasc. Surg. 2005, 130:1310.
8. Fishbein M.C., Maclean D., Maroko P.R. Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am. J. Pathol. 1978, 90:57-70.
9. Frangogiannis N.G. Targeting the inflammatory response in healing myocardial infarcts. Curr. Med. Chem. 2006, 13:1877-1893.
10. Freyman T., Polin G., Osman H., et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur. Heart J. 2006, 27:1114-1122.
11. Fujikura D., Ito M., Chiba S., et al. CLIPR-59 regulates TNF-alpha-induced apoptosis by controlling ubiquitination of RIP1. Cell. Death Dis. 2012, 3:e264.
12. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 1992, 119:493-501.
13. Gnecchi M., He H., Noiseux N., et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 2006, 20:661-669.
14. Gyongyosi M., Blanco J., Marian T., et al. Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression. Circ. Cardiovasc. Imaging 2008, 1:94-103.
15. Hahn J.Y., Cho H.J., Kang H.J., et al. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J. Am. Coll. Cardiol. 2008, 51:933-943.
16. Halkos M.E., Zhao Z.Q., Kerendi F., et al. Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction. Basic Res. Cardiol. 2008, 103:525-536.
17. Hare J.M., Fishman J.E., Gerstenblith G., et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 2012, 308:2369-2379.
18. He K.L., Ting A.T. A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells. Mol. Cell. Biol. 2002, 22:6034-6045.
19. Houbaviy H.B., Murray M.F., Sharp P.A. Embryonic stem cell-specific MicroRNAs. Dev. Cell 2003, 5:351-358.
20. Jackson K.A., Majka S.M., Wang H., et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 2001, 107:1395-1402.
21. Kim H., Kim S.W., Nam D., Kim S., Yoon Y.S. Cell therapy with bone marrow cells for myocardial regeneration. Antioxid. Redox Signal. 2009, 11:1897-1911.
22. Kofidis T., de Bruin J.L., Yamane T., et al. Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration. Stem Cells 2004, 22:1239-1245.
23. Kozomara A., Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011, 39:D152-D157.
24. Krijnen P.A., Nijmeijer R., Meijer C.J., Visser C.A., Hack C.E., Niessen H.W. Apoptosis in myocardial ischaemia and infarction. J. Clin. Pathol. 2002, 55:801-811.
25. Kudo M., Wang Y., Wani M.A., Xu M., Ayub A., Ashraf M. Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. J. Mol. Cell. Cardiol. 2003, 35:1113-1119.
26. Li R.K., Mickle D.A., Weisel R.D., Rao V., Jia Z.Q. Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann. Thorac. Surg. 2001, 72:1957-1963.
27. Li Z., Guo J., Chang Q., Zhang A. Paracrine role for mesenchymal stem cells in acute myocardial infarction. Biol. Pharm. Bull. 2009, 32:1343-1346.
28. Lin Z., Murtaza I., Wang K., Jiao J., Gao J., Li P.F. miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:12103-12108.
29. Lin H., Qian J., Castillo A.C., et al. Effect of miR-23 on oxidant-induced injury in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 2011, 52:6308-6314.
30. Liu Y., Wang L., Kikuiri T., et al. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-gamma and TNF-alpha. Nat. Med. 2011, 17:1594-1601.
31. Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001, 104:487-501.
32. Martin-Ventura J.L., Munoz-Garcia B., Egido J., Blanco-Colio L.M. Trail and vascular injury. Front. Biosci. 2007, 12:3656-3667.
33. Miyahara Y., Nagaya N., Kataoka M., et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med. 2006, 12:459-465.
34. Mylotte L.A., Duffy A.M., Murphy M., et al. Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment. Stem Cells 2008, 26:1325-1336.
35. Nie Y., Han B.M., Liu X.B., et al. Identification of MicroRNAs involved in hypoxia- and serum deprivation-induced apoptosis in mesenchymal stem cells. Int. J. Biol. Sci. 2011, 7:762-768.
36. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
37. Pasquinelli A.E. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat. Rev. Genet. 2012, 13:271-282.
38. Piao H., Youn T.J., Kwon J.S., et al. Effects of bone marrow derived mesenchymal stem cells transplantation in acutely infarcting myocardium. Eur. J. Heart Fail. 2005, 7:730-738.
39. Pritchard C.C., Cheng H.H., Tewari M. MicroRNA profiling: approaches and considerations. Nat. Rev. Genet. 2012, 13:358-369.
40. Quevedo H.C., Hatzistergos K.E., Oskouei B.N., et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14022-14027.
41. Ray R., Novotny N.M., Crisostomo P.R., Lahm T., Abarbanell A., Meldrum D.R. Sex steroids and stem cell function. Mol. Med. 2008, 14:493-501.
42. Ruan W., Xu J.M., Li S.B., Yuan L.Q., Dai R.P. Effects of down-regulation of microRNA-23a on TNF-alpha-induced endothelial cell apoptosis through caspase-dependent pathways. Cardiovasc. Res. 2012, 93:623-632.
43. Sayed D., Abdellatif M. MicroRNAs in development and disease. Physiol. Rev. 2011, 91:827-887.
44. Silva G.V., Litovsky S., Assad J.A., et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005, 111:150-156.
45. Song H., Song B.W., Cha M.J., Choi I.G., Hwang K.C. Modification of mesenchymal stem cells for cardiac regeneration. Expert Opin. Biol. Ther. 2010, 10:309-319.
46. Strauer B.E., Brehm M., Zeus T., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002, 106:1913-1918.
47. Suh M.R., Lee Y., Kim J.Y., et al. Human embryonic stem cells express a unique set of microRNAs. Dev. Biol. 2004, 270:488-498.
48. Suzuki K., Sawa Y., Kagisaki K., et al. Reduction in myocardial apoptosis associated with overexpression of heat shock protein 70. Basic Res. Cardiol. 2000, 95:397-403.
49. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002, 105:93-98.
50. Valensi P., Lorgis L., Cottin Y. Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature. Arch. Cardiovasc. Dis. 2011, 104:178-188.
51. Wagner-Ecker M., Schwager C., Wirkner U., Abdollahi A., Huber P.E. MicroRNA expression after ionizing radiation in human endothelial cells. Radiat. Oncol. 2010, 5:25.
52. Wang X.H., Qian R.Z., Zhang W., Chen S.F., Jin H.M., Hu R.M. MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin. Exp. Pharmacol. Physiol. 2009, 36:181-188.
53. Wang K., Lin Z.Q., Long B., Li J.H., Zhou J., Li P.F. Cardiac hypertrophy is positively regulated by MicroRNA miR-23a. J. Biol. Chem. 2012, 287:589-599.
54. Zauli G., Secchiero P. The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology. Cytokine Growth Factor Rev. 2006, 17:245-257.